+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurology Contract Research Organization Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 244 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5924981
Description Jump to:
The global neurology contract research organization market reached a revenue of US$ 7.9 billion in 2024 and is poised for significant expansion, to attain US$ 13.8 billion by 2031.

Rapid Growth Attributed to Increasing Adoption of Outsourcing

The rapid expansion of neurology contract research organizations can be attributed to the substantial adoption of outsourcing by pharmaceutical and biotechnology companies. Outsourcing clinical development of drugs and medical devices has proven efficient and cost-effective, leading to increased R&D productivity. Factors such as the pursuit of improved return on investment, alignment with scientific advancements, and compliance with strict government regulations have driven this trend.

The rising prevalence of neurological disorders has resulted in a surge in pharmacological therapies, reflected in the significant development of neurological drugs. This growth is underscored by the development of numerous pharmaceuticals across various therapeutic areas, including neurology.

Challenges in the Availability of Skilled Professionals

However, neurology CROs face a challenge in acquiring highly skilled professionals. Competing with pharmaceutical companies, biopharmaceutical companies, medical device companies, and academic and research organizations for skilled experts, particularly neuroscientists, poses a potential limitation to the growth of the global neurology CRO market.

Country-wise Insights

U.S. Neurology CRO Market Booms

The United States accounts for a substantial share of the North American neurology CRO market in 2023. The country's market is thriving due to the rising prevalence of neurological disorders, particularly Alzheimer's disease, and the lack of effective diagnosis methods. The presence of leading CROs in the U.S., including Laboratory Corporation of America Holdings, IQVIA Inc., Parexel International Corporation, and Charles River Laboratories, has further bolstered the market.

Lucrative Opportunities in the U.K.

In the United Kingdom, major pharmaceutical and biotech companies have increasingly outsourced drug discovery and development activities, including neurology. This trend, driven by the complex drug lifecycle and pricing pressure from government bodies, is favorable for neurology CROs. The U.K. also witnesses an uptick in mergers, acquisitions, and private equity investments, which are expected to positively influence the neurology contract research organization market.

China Emerges as a Prominent Market

China captured the largest market share of the global neurology CRO market in 2021. CROs in China offer cost-effective clinical development services, attracting pharmaceutical companies like GSK and Novartis, which have closed their R&D centers in the country to focus on outsourcing R&D activities. The increasing revenue of CROs in China, including Pharmaron Beijing Co., Ltd., highlights the significant growth of the neurology research organization market in the nation.

Competitive Analysis

Key players in the neurology CRO market are strategically enhancing their global presence through collaborations, expansions, mergers, and acquisitions. These actions are driving advancements in the neurology contract research organization industry.

Key Companies Profiled

  • Charles River Laboratories
  • Laboratory Corporation of America Holdings
  • IQVIA Inc.
  • Syneos Health
  • Parexel International Corporation
  • ICON Plc.
  • Medpace
  • Axon CRO
  • Thermo Fisher Scientific Inc. (PPD Inc.)
  • CTI Clinical Trial & Consulting
  • Pharmaron Beijing Co., Ltd.
  • Neuroservices-Alliance
  • QPS Neuropharmacology
  • MD Biosciences
  • Atlantic Research Group, Inc.
  • EphyX Neuroscience
  • Ergomed plc
  • Neuron Experts

Segmentation of Neurology Contract Research Organization Industry Research

Neurology Contract Research Organization Market by Service:

  • Clinical Services
  • Early Phase/Phase I Development
  • Phase IIB-III Clinical Trials
  • Phase IIIB-Phase IV Clinical Trials
  • 510(k) Clinical Studies
  • IDE Clinical Studies
  • IND Clinical Studies
  • PMA Clinical Studies
  • De Novo Clinical Studies
  • Retrospective Clinical Studies
  • Data Management Services
  • Clinical Database Selection
  • Clinical Study Planning and Clinical Protocol Development
  • Clinical Site Budget Development
  • Data Management (DM) and Biostatistics (BS)
  • Drug Safety
  • Medical and Scientific Writing
  • Regulatory Affairs
  • Pharmacology and Toxicology
  • Quality and Compliance

Neurology Contract Research Organization Market by Study:

  • Neuroscience focused
  • Neurology focused

Neurology Contract Research Organization Market by Indication:

  • Alzheimer's Disease
  • Brain Tumors
  • Epilepsy & Seizures
  • Headaches
  • Schizophrenia
  • Depressive Disorder
  • Multiple Sclerosis (MS)
  • Muscular Dystrophy
  • Parkinson's Disease
  • Progressive Muscular Atrophy (PMA)
  • Stroke
  • Psychiatry
  • Autism Spectrum Disorder
  • Cerebral Adrenoleukodystrophy (CALD)
  • Sleep Apnea/ Sleep Dysfunction

Neurology Contract Research Organization Market by End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Biopharmaceutical Companies
  • Medical Device Companies
  • Academic and Research Institutes

Neurology Contract Research Organization Market by Region:

  • North America Neurology Contract Research Organization Market
  • Latin America Neurology Contract Research Organization Market
  • Europe Neurology Contract Research Organization Market
  • South Asia Neurology Contract Research Organization Market
  • East Asia Neurology Contract Research Organization Market
  • Oceania Neurology Contract Research Organization Market
  • Middle East and Africa Neurology Contract Research Organization Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Neurology Contract Research Organization Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurology Contract Research Organization Market Outlook, 2018 - 2031
3.1. Global Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Clinical Services
3.1.1.1.1. Early Phase/Phase I Development
3.1.1.1.2. Phase IIB-III Clinical Trials
3.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
3.1.1.1.4. 510(k) Clinical Studies
3.1.1.1.5. IDE Clinical Studies
3.1.1.1.6. IND Clinical Studies
3.1.1.1.7. PMA Clinical Studies
3.1.1.1.8. De Novo Clinical Studies
3.1.1.1.9. Retrospective Clinical Studies
3.1.1.2. Data Management Services
3.1.1.2.1. Clinical Database Selection
3.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
3.1.1.2.3. Clinical Site Budget Development
3.1.1.2.4. Data Management (DM) and Biostatistics (BS)
3.1.1.3. Drug Safety
3.1.1.4. Medical and Scientific Writing
3.1.1.5. Regulatory Affairs
3.1.1.6. Pharmacology and Toxicology
3.1.1.7. Quality and Compliance
3.2. Global Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Neuroscience focused.
3.2.1.2. Neurology focused.
3.3. Global Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Alzheimer's Disease
3.3.1.2. Brain Tumors
3.3.1.3. Epilepsy & Seizures
3.3.1.4. Headaches
3.3.1.5. Schizophrenia
3.3.1.6. Depressive Disorder
3.3.1.7. Multiple Sclerosis (MS)
3.3.1.8. Muscular Dystrophy
3.3.1.9. Parkinson's Disease
3.3.1.10. Progressive Muscular Atrophy (PMA)
3.3.1.11. Stroke
3.3.1.12. Psychiatry
3.3.1.13. Autism Spectrum Disorder
3.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
3.3.1.15. Sleep Apnea/ Sleep Dysfunction
3.4. Global Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Pharmaceutical & Biopharmaceutical Companies
3.4.1.2. Biopharmaceutical Companies
3.4.1.3. Medical Device Companies
3.4.1.4. Academic and Research Institutes
3.5. Global Neurology Contract Research Organization Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Neurology Contract Research Organization Market Outlook, 2018 - 2031
4.1. North America Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Clinical Services
4.1.1.1.1. Early Phase/Phase I Development
4.1.1.1.2. Phase IIB-III Clinical Trials
4.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
4.1.1.1.4. 510(k) Clinical Studies
4.1.1.1.5. IDE Clinical Studies
4.1.1.1.6. IND Clinical Studies
4.1.1.1.7. PMA Clinical Studies
4.1.1.1.8. De Novo Clinical Studies
4.1.1.1.9. Retrospective Clinical Studies
4.1.1.2. Data Management Services
4.1.1.2.1. Clinical Database Selection
4.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
4.1.1.2.3. Clinical Site Budget Development
4.1.1.2.4. Data Management (DM) and Biostatistics (BS)
4.1.1.3. Drug Safety
4.1.1.4. Medical and Scientific Writing
4.1.1.5. Regulatory Affairs
4.1.1.6. Pharmacology and Toxicology
4.1.1.7. Quality and Compliance
4.2. North America Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Neuroscience focused.
4.2.1.2. Neurology focused.
4.3. North America Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Alzheimer's Disease
4.3.1.2. Brain Tumors
4.3.1.3. Epilepsy & Seizures
4.3.1.4. Headaches
4.3.1.5. Schizophrenia
4.3.1.6. Depressive Disorder
4.3.1.7. Multiple Sclerosis (MS)
4.3.1.8. Muscular Dystrophy
4.3.1.9. Parkinson's Disease
4.3.1.10. Progressive Muscular Atrophy (PMA)
4.3.1.11. Stroke
4.3.1.12. Psychiatry
4.3.1.13. Autism Spectrum Disorder
4.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
4.3.1.15. Sleep Apnea/ Sleep Dysfunction
4.4. North America Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Pharmaceutical & Biopharmaceutical Companies
4.4.1.2. Biopharmaceutical Companies
4.4.1.3. Medical Device Companies
4.4.1.4. Academic and Research Institutes
4.5. North America Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurology Contract Research Organization Market Outlook, 2018 - 2031
5.1. Europe Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Clinical Services
5.1.1.1.1. Early Phase/Phase I Development
5.1.1.1.2. Phase IIB-III Clinical Trials
5.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
5.1.1.1.4. 510(k) Clinical Studies
5.1.1.1.5. IDE Clinical Studies
5.1.1.1.6. IND Clinical Studies
5.1.1.1.7. PMA Clinical Studies
5.1.1.1.8. De Novo Clinical Studies
5.1.1.1.9. Retrospective Clinical Studies
5.1.1.2. Data Management Services
5.1.1.2.1. Clinical Database Selection
5.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
5.1.1.2.3. Clinical Site Budget Development
5.1.1.2.4. Data Management (DM) and Biostatistics (BS)
5.1.1.3. Drug Safety
5.1.1.4. Medical and Scientific Writing
5.1.1.5. Regulatory Affairs
5.1.1.6. Pharmacology and Toxicology
5.1.1.7. Quality and Compliance
5.2. Europe Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Neuroscience focused.
5.2.1.2. Neurology focused.
5.3. Europe Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Alzheimer's Disease
5.3.1.2. Brain Tumors
5.3.1.3. Epilepsy & Seizures
5.3.1.4. Headaches
5.3.1.5. Schizophrenia
5.3.1.6. Depressive Disorder
5.3.1.7. Multiple Sclerosis (MS)
5.3.1.8. Muscular Dystrophy
5.3.1.9. Parkinson's Disease
5.3.1.10. Progressive Muscular Atrophy (PMA)
5.3.1.11. Stroke
5.3.1.12. Psychiatry
5.3.1.13. Autism Spectrum Disorder
5.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
5.3.1.15. Sleep Apnea/ Sleep Dysfunction
5.4. Europe Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pharmaceutical & Biopharmaceutical Companies
5.4.1.2. Biopharmaceutical Companies
5.4.1.3. Medical Device Companies
5.4.1.4. Academic and Research Institutes
5.5. Europe Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurology Contract Research Organization Market Outlook, 2018 - 2031
6.1. Asia Pacific Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Clinical Services
6.1.1.1.1. Early Phase/Phase I Development
6.1.1.1.2. Phase IIB-III Clinical Trials
6.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
6.1.1.1.4. 510(k) Clinical Studies
6.1.1.1.5. IDE Clinical Studies
6.1.1.1.6. IND Clinical Studies
6.1.1.1.7. PMA Clinical Studies
6.1.1.1.8. De Novo Clinical Studies
6.1.1.1.9. Retrospective Clinical Studies
6.1.1.2. Data Management Services
6.1.1.2.1. Clinical Database Selection
6.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
6.1.1.2.3. Clinical Site Budget Development
6.1.1.2.4. Data Management (DM) and Biostatistics (BS)
6.1.1.3. Drug Safety
6.1.1.4. Medical and Scientific Writing
6.1.1.5. Regulatory Affairs
6.1.1.6. Pharmacology and Toxicology
6.1.1.7. Quality and Compliance
6.2. Asia Pacific Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Neuroscience focused.
6.2.1.2. Neurology focused.
6.3. Asia Pacific Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Alzheimer's Disease
6.3.1.2. Brain Tumors
6.3.1.3. Epilepsy & Seizures
6.3.1.4. Headaches
6.3.1.5. Schizophrenia
6.3.1.6. Depressive Disorder
6.3.1.7. Multiple Sclerosis (MS)
6.3.1.8. Muscular Dystrophy
6.3.1.9. Parkinson's Disease
6.3.1.10. Progressive Muscular Atrophy (PMA)
6.3.1.11. Stroke
6.3.1.12. Psychiatry
6.3.1.13. Autism Spectrum Disorder
6.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
6.3.1.15. Sleep Apnea/ Sleep Dysfunction
6.4. Asia Pacific Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pharmaceutical & Biopharmaceutical Companies
6.4.1.2. Biopharmaceutical Companies
6.4.1.3. Medical Device Companies
6.4.1.4. Academic and Research Institutes
6.5. Asia Pacific Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurology Contract Research Organization Market Outlook, 2018 - 2031
7.1. Latin America Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Clinical Services
7.1.1.1.1. Early Phase/Phase I Development
7.1.1.1.2. Phase IIB-III Clinical Trials
7.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
7.1.1.1.4. 510(k) Clinical Studies
7.1.1.1.5. IDE Clinical Studies
7.1.1.1.6. IND Clinical Studies
7.1.1.1.7. PMA Clinical Studies
7.1.1.1.8. De Novo Clinical Studies
7.1.1.1.9. Retrospective Clinical Studies
7.1.1.2. Data Management Services
7.1.1.2.1. Clinical Database Selection
7.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
7.1.1.2.3. Clinical Site Budget Development
7.1.1.2.4. Data Management (DM) and Biostatistics (BS)
7.1.1.3. Drug Safety
7.1.1.4. Medical and Scientific Writing
7.1.1.5. Regulatory Affairs
7.1.1.6. Pharmacology and Toxicology
7.1.1.7. Quality and Compliance
7.2. Latin America Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Neuroscience focused.
7.2.1.2. Neurology focused.
7.3. Latin America Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Alzheimer's Disease
7.3.1.2. Brain Tumors
7.3.1.3. Epilepsy & Seizures
7.3.1.4. Headaches
7.3.1.5. Schizophrenia
7.3.1.6. Depressive Disorder
7.3.1.7. Multiple Sclerosis (MS)
7.3.1.8. Muscular Dystrophy
7.3.1.9. Parkinson's Disease
7.3.1.10. Progressive Muscular Atrophy (PMA)
7.3.1.11. Stroke
7.3.1.12. Psychiatry
7.3.1.13. Autism Spectrum Disorder
7.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
7.3.1.15. Sleep Apnea/ Sleep Dysfunction
7.4. Latin America Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Pharmaceutical & Biopharmaceutical Companies
7.4.1.2. Biopharmaceutical Companies
7.4.1.3. Medical Device Companies
7.4.1.4. Academic and Research Institutes
7.5. Latin America Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurology Contract Research Organization Market Outlook, 2018 - 2031
8.1. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Clinical Services
8.1.1.1.1. Early Phase/Phase I Development
8.1.1.1.2. Phase IIB-III Clinical Trials
8.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
8.1.1.1.4. 510(k) Clinical Studies
8.1.1.1.5. IDE Clinical Studies
8.1.1.1.6. IND Clinical Studies
8.1.1.1.7. PMA Clinical Studies
8.1.1.1.8. De Novo Clinical Studies
8.1.1.1.9. Retrospective Clinical Studies
8.1.1.2. Data Management Services
8.1.1.2.1. Clinical Database Selection
8.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
8.1.1.2.3. Clinical Site Budget Development
8.1.1.2.4. Data Management (DM) and Biostatistics (BS)
8.1.1.3. Drug Safety
8.1.1.4. Medical and Scientific Writing
8.1.1.5. Regulatory Affairs
8.1.1.6. Pharmacology and Toxicology
8.1.1.7. Quality and Compliance
8.2. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Neuroscience focused.
8.2.1.2. Neurology focused.
8.3. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Alzheimer's Disease
8.3.1.2. Brain Tumors
8.3.1.3. Epilepsy & Seizures
8.3.1.4. Headaches
8.3.1.5. Schizophrenia
8.3.1.6. Depressive Disorder
8.3.1.7. Multiple Sclerosis (MS)
8.3.1.8. Muscular Dystrophy
8.3.1.9. Parkinson's Disease
8.3.1.10. Progressive Muscular Atrophy (PMA)
8.3.1.11. Stroke
8.3.1.12. Psychiatry
8.3.1.13. Autism Spectrum Disorder
8.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
8.3.1.15. Sleep Apnea/ Sleep Dysfunction
8.4. Middle East & Africa Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmaceutical & Biopharmaceutical Companies
8.4.1.2. Biopharmaceutical Companies
8.4.1.3. Medical Device Companies
8.4.1.4. Academic and Research Institutes
8.5. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Artery Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Charles River Laboratories
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Laboratory Corporation of America Holdings
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. IQVIA Inc.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Syneos Health
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Parexel International Corporation
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. ICON Plc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Medpace
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Axon CRO
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Thermo Fisher Scientific Inc. (PPD Inc.)
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. CTI Clinical Trial & Consulting
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Pharmaron Beijing Co., Ltd.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Neuroservices-Alliance
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. QPS Neuropharmacology
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. MD Biosciences
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Atlantic Research Group, Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. EphyX Neuroscience
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Ergomed plc
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Neuron Experts
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Charles River Laboratories
  • Laboratory Corporation of America Holdings
  • IQVIA Inc.
  • Parexel International Corporation
  • ICON plc.
  • Medpace
  • Syneos Health
  • Thermo Fisher Scientific (PPD Inc.)
  • Pharmaron Beijing Co., Ltd.
  • Neuroservices Alliance
  • QPS Neuropharmacology
  • MD Biosciences
  • CTI Clinical Trial and Consulting Services
  • Atlantic Research Group, Inc.
  • EphyX Neuroscience
  • Ergomed PLC
  • Neuron Experts
  • Axon CRO

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Contract Research Organization (CRO) Services Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Contract Research Organization (CRO) Services Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 224 Pages
  • Global
From
Global Contract Research Organization Services Market Analysis & Forecast to 2023-2033: Market By Service; By Application; By End-user; and By Region - Product Image

Global Contract Research Organization Services Market Analysis & Forecast to 2023-2033: Market By Service; By Application; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030 - Product Image

Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029 - Product Image

Global Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029

  • Report
  • 483 Pages
  • Global
From
Global Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Forecast 2024-2030 - Product Image

Global Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.